Beta
77436

Montelukast Efficiency in Improving the Deleterious Gastrointestinal Effects of Dexamethasone in Rats

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

-

Abstract

Abstract Background: Montelukast and dexamethasone are used in combination in the treatment of asthma. Treatment by steroids resulted in gastric mucosa weakening enhancing the occurrence of ulcer in addition to its effect on the motility and contractility of gastrointestinal tract. Aim of Study: The present study was designed to evaluate the anti-ulcer effect of montelukast, a selective leukotriene (LT) D4 receptor antagonist compared to famotidine and its effect on the motility and contractility of the small intestine in gastric ulcer induced by dexamethasone and aggravated by cold stress. Material and Methods: Adult male rats were divided into 5 groups: The first received normal saline. The other groups were given dexamethasone intraperitoneally (4mg/kg/day) for 5 days. The third group received famotidine 40mg/kg/day while the fourth and fifth groups received montelukast 30 and 60mg/kg/day orally respectively thirty minutes after dexam-ethasone. At the end, rats were exposed to cold stress then sacrificed to extract the stomachs and intestines to determine gastric ulcer score and intestinal transit then the response of small intestine to acetyl choline was recorded. Then the stomachs were divided for histopathological and biochemical studies. Results: Dexamethasone treatment resulted in ulceration of gastric mucosa, increased intestinal transit, diminished intestinal contraction and increased oxidative stress. The group treated with montelukast 60mg/kg/day showed a sig-nificant decrease in mean gastric ulcer score, intestinal transit but increase of intestinal contractility. All treated groups showed significant MDA decrease, improved histopathological picture of the stomach while the two montelukast treated groups showed significant increase in SOD. Conclusion: Montelukast with high dose shows a prom-ising role in eliminating the undesirable effects induced by corticosteroids especially if associated with stress.

DOI

10.21608/mjcu.2019.77436

Keywords

Montelukast – Dexamethasone – Famotidine – Intestinal transit – Gastric ulcer

Authors

First Name

GHADA F. SOLIMAN, M.D.;

Last Name

MARIAN Y. WISSA, M.D.

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

HEBA

Last Name

MORSI, M.D.

MiddleName

-

Affiliation

The Departments of Medical Pharmacology* and Medical Biochemistry & Molecular Biology**, Faculty of Medicine, Cairo University, Egypt

Email

-

City

-

Orcid

-

Volume

87

Article Issue

December

Related Issue

11480

Issue Date

2019-12-01

Receive Date

2019-03-15

Publish Date

2019-12-01

Page Start

4,303

Page End

4,313

Print ISSN

0045-3803

Online ISSN

2536-9806

Link

https://mjcu.journals.ekb.eg/article_77436.html

Detail API

https://mjcu.journals.ekb.eg/service?article_code=77436

Order

38

Type

Original Article

Type Code

263

Publication Type

Journal

Publication Title

The Medical Journal of Cairo University

Publication Link

https://mjcu.journals.ekb.eg/

MainTitle

Montelukast Efficiency in Improving the Deleterious Gastrointestinal Effects of Dexamethasone in Rats

Details

Type

Article

Created At

22 Jan 2023